PRKAA1 and type 2 diabetes mellitus: In a recent report, researchers found that metformin, a commonly used medication for type 2 diabetes, activates the tristetraprolin (TTP) via the AMPK–SIRT1 pathway in hepatocytes and Kupffer cells (KCs).